Cell Signaling Technology and Beyond Benign collaborate to advance green chemistry education

Cell Signaling Technology (CST), a life science discovery technology company and leading provider of antibodies, kits, and services, today announced a partnership with global green chemistry education nonprofit Beyond Benign.

Vim CEO Talks Solving the Rising Tide of Healthcare Claim Denials

Oron Afek, CEO of Vim The U.S. healthcare system is grappling with a surge in claim denials and prior authorization requirements, creating significant challenges for

November 7, 2024

Illumina reports stronger-than-expected growth, indicates Grail divestiture still in early stages: #JPM24

Illumina’s stock rose after reporting stronger quarterly revenue than expected, while company executives during the JP Morgan Healthcare Conference indicated cancer-testing subsidiary Grail won’t be divested imminently. The

January 10, 2024

Estetrol by Mithra Pharmaceuticals for Genitourinary Syndrome of Menopause (GSM): Likelihood of Approval

Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug

April 18, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.